New Talk Show Focuses on Pharma PAT and Quality by Design

To some people, Process Analytical Technologies (PAT) and Quality by Design (QbD) might seem like the dullest topics imagineable. But they just might be the salvation of an industry dogged by recalls and adverse reaction reports, lawsuits, 483's and other compliance issues (and that's just on the GMP and non sales and marketing side!) We think they need to be discussed openly and engagingly, and we've invited two experts whose erudition doesn't get in the way of their common sense, sense of humor and connection to broader culture...and yes, that includes (gasp) pop culture...to help lead an open discussion about this. Jack Carroll and Emil Ciurczak, chemists and experts in spectroscopy and chemometrics, who teach courses on PAT, QbD and other topics around the world, are co-hosting a video and audio talk show, PAT Talk, to discuss issues. Here's the first video pilot. We're planning to feature this regularly in either audio or video format, and to open the discussion and, eventually, allow viewers or listeners to ask Emil and Jack questions about their implementation problems, much as Tom and Ray Magliozzi (better known as Click and Clak, the Tappet Brothers) do on the program, Car Talk. Eventually, guest experts will be invited and the program will also feature "puzzlers." We hope that you enjoy the program, and welcome any comments, constructive criticism or questions. Especially comments! These subjects can't just be discussed by the elite but need to be talked about openly by everyone in the industry. AMS
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

  • <p>Select effective error reduction strategies that can prevent patient harm.-<a href="http://kylethomasglasser.com/kyle-thomas-glasser-experiences-life-changing-opportunities-on-missions-trip-to-central-america/">Kyle Thomas Glasser</a></p>

    Reply

RSS feed for comments on this page | RSS feed for all comments